Major bleeding after hospitalization for deep-venous thrombosis.
about
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAssessing the risk of recurrent venous thromboembolism--a practical approachAtrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institutePredicting the risk of venous thromboembolism recurrenceScreening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimersCharacterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study.Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study.Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.Pharmacogenetics of anticoagulants.Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant TreatmentDo anticoagulants improve survival in patients presenting with venous thromboembolism?Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial FibrillationAlcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.Initiating warfarin therapy: 5 mg versus 10 mg.Genetic-based dosing in orthopedic patients beginning warfarin therapy.Low-molecular-weight heparin for the treatment of venous thromboembolism in the elderly.Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial FibrillationEffectiveness of warfarin among patients with cancerThe risks of warfarin use in the elderly.Ginkgo and Warfarin Interaction in a Large Veterans Administration PopulationUse of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinEthnic differences in cardiovascular drug response: potential contribution of pharmacogeneticsPrimary prevention of venous thromboembolism in elderly medical patients[Overdose in Vitamin K antagonists administration in Dakar: epidemiological, clinical and evolutionary aspects].Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature.Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill.Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry.
P2860
Q24633053-9BC90EA6-A57E-4130-ADF2-5734DC312B77Q26796430-97A29AA8-33EF-41CB-85DD-BE24DF8A0F1FQ26851235-04E59BAE-B90D-401B-865B-D22178400175Q26865059-F2E9E90C-05B3-4E34-A096-C10762C92771Q28217653-233472D6-1B70-460B-B267-FF9C875A4E03Q30939373-CDE5E2BF-87BD-4D28-8199-7736B456319FQ30996878-78A0B704-C4FE-41DA-93A3-0813ADEEAC6BQ33232061-E719D447-28C0-45F7-A323-2A3B6C1C28EDQ33685299-95704A1A-27F5-4BDC-A771-E125398FBB34Q33770184-65EF12CC-65DC-4F51-8F71-A381D358EFDBQ33792352-7770E438-0089-430F-9E28-8259299ACD1CQ34061511-1A570E2C-8F91-433E-BB29-EA13AB1D9EB8Q34219746-749B3B64-A02F-4CAA-AFD0-5DEB9907EE1DQ35016262-D7EA454B-C54E-457B-A177-1BD99A7AE1BFQ35218128-80BE7745-6F28-4CCF-9CA2-DC3B632CCB2AQ35532385-9AE520AE-D19D-493A-A3C8-2AEB8A8A5680Q35594629-73EA8723-7CE9-4359-8430-2E8889DCF9B0Q35638248-DDD6DC12-2618-4057-8AE9-814296074329Q35772034-B08ED56A-E31D-469E-8114-63FAFC08C14CQ35790677-1F1BC5B0-F02C-4B21-8575-63D89371AEFAQ35937712-07044FA8-0A3C-48A6-80C9-5701E62EB7BEQ35989429-1FD07036-0E0E-41ED-86AB-E76617EEBAC7Q36022983-C557BCA3-5A41-48F7-86CA-4761BB61A158Q36307322-F90C4233-5B42-4208-9CF9-365FE4ED4EABQ36416675-BAD35DD0-054A-4684-9F12-614CBB41563FQ36446904-1F37F96A-5BA9-4789-AAF4-350C1D87C79BQ36613264-215FECD4-BDC5-4C78-A2F9-B9D9FED2C575Q37196787-F4104967-CD3B-408D-AA46-051D23EFF90DQ37276490-D9396C59-5871-4002-9669-21397F61BA36Q37316796-E72FF4B2-9BF7-44DD-A92A-173808359637Q37354620-E7597CB6-7A33-4D22-B51B-20F09751D837Q37890023-EBC17D57-F14E-4B06-AF66-A44DD7201450Q38096441-4B6F4760-8AC5-4077-AFB3-2ECE5F211EDDQ38728371-D389E898-AF6F-47C6-A1D2-2603113B8230Q38824447-42E10042-80EF-4768-83EF-DE69A586308CQ39093192-F38AA731-3B14-4AF6-BBC9-CDA48771DE8EQ40670636-91B14865-EA6F-4C3F-823F-8962C27073F8Q40673191-E940B735-F6ED-4D0B-9295-A76D8F0A4AB9Q42627777-70714EA9-1E22-4D92-B561-F1B5963A2FF4Q43620262-F2C20340-4001-4D76-97C2-3DF736EE6326
P2860
Major bleeding after hospitalization for deep-venous thrombosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Major bleeding after hospitalization for deep-venous thrombosis.
@en
type
label
Major bleeding after hospitalization for deep-venous thrombosis.
@en
prefLabel
Major bleeding after hospitalization for deep-venous thrombosis.
@en
P2093
P1476
Major bleeding after hospitalization for deep-venous thrombosis
@en
P2093
P304
P356
10.1016/S0002-9343(99)00267-3
P407
P577
1999-11-01T00:00:00Z